Disorders of cholesterol biosynthesis.
作者信息
Clayton P T
机构信息
Biochemistry Unit, Great Ormond Street Hospital for Children, London.
出版信息
Arch Dis Child. 1998 Feb;78(2):185-9. doi: 10.1136/adc.78.2.185.
Abstract
摘要
相似文献
1
Disorders of cholesterol biosynthesis.
Arch Dis Child. 1998 Feb;78(2):185-9. doi: 10.1136/adc.78.2.185.
2
Abnormal cholesterol biosynthesis produced by AY 9944 in the rat leads to skeletal deformities similar to the Smith-Lemli-Opitz syndrome.
J Lab Clin Med. 1998 Mar;131(3):192-3. doi: 10.1016/s0022-2143(98)90088-9.
3
Signaling by the human serotonin(1A) receptor is impaired in cellular model of Smith-Lemli-Opitz Syndrome.
Biochim Biophys Acta. 2008 Jun;1778(6):1508-16. doi: 10.1016/j.bbamem.2008.03.002. Epub 2008 Mar 12.
4
Novel oxysterols observed in tissues and fluids of AY9944-treated rats: a model for Smith-Lemli-Opitz syndrome.
J Lipid Res. 2011 Oct;52(10):1810-20. doi: 10.1194/jlr.M018366. Epub 2011 Aug 4.
5
Reactivity of key metabolic sterols in standard colorimetric assays for cholesterol.
Lipids. 1982 Jan;17(1):46-9. doi: 10.1007/BF02535121.
6
[Cholesterol and development].
C R Seances Soc Biol Fil. 1997;191(1):113-23.
7
Effect of hypocholesterolemic agents on central nervous system cholesterol biosynthesis. II. AY-9944 and AY-9944 plus zuclomiphene.
Biochem Pharmacol. 1977 Jun 15;26(12):1169-73. doi: 10.1016/0006-2952(77)90063-6.
8
Effect of hypocholesterolemic agents on central nervous system cholesterol biosynthesis III. Zuclomiphene in combination with AY9944 and triparanol.
Biochem Pharmacol. 1978;27(12):1637-40. doi: 10.1016/0006-2952(78)90172-7.
9
Cholesterol biosynthesis from lanosterol: regulation and purification of rat hepatic sterol 8-isomerase.
J Biochem. 1995 Apr;117(4):819-23. doi: 10.1093/oxfordjournals.jbchem.a124781.
10
Retinal degeneration in a rodent model of Smith-Lemli-Opitz syndrome: electrophysiologic, biochemical, and morphologic features.
Arch Ophthalmol. 2004 Aug;122(8):1190-200. doi: 10.1001/archopht.122.8.1190.
引用本文的文献
1
Conradi-Hünerman-Happle Syndrome and Obsessive-Compulsive Disorder: a clinical case report.
BMC Psychiatry. 2023 Feb 6;23(1):87. doi: 10.1186/s12888-023-04579-1.
2
Lactiplantibacillus plantarum PGB02 Improved Serum Cholesterol Profile by Tweaking Genes Involved in Cholesterol Homeostasis in Male Swiss Albino Mice.
Appl Biochem Biotechnol. 2023 May;195(5):3180-3193. doi: 10.1007/s12010-022-04307-7. Epub 2022 Dec 27.
3
Respiratory deficiency in yeast mevalonate kinase deficient may explain MKD-associate metabolic disorder in humans.
Curr Genet. 2018 Aug;64(4):871-881. doi: 10.1007/s00294-018-0803-2. Epub 2018 Jan 27.
4
Desmosterolosis presenting with multiple congenital anomalies.
Eur J Med Genet. 2018 Mar;61(3):152-156. doi: 10.1016/j.ejmg.2017.11.009. Epub 2017 Nov 23.
5
Cholesterol up-regulates neuronal G protein-gated inwardly rectifying potassium (GIRK) channel activity in the hippocampus.
J Biol Chem. 2017 Apr 14;292(15):6135-6147. doi: 10.1074/jbc.M116.753350. Epub 2017 Feb 17.
6
Desmosterol in brain is elevated because DHCR24 needs REST for Robust Expression but REST is poorly expressed.
Dev Neurosci. 2014;36(2):132-42. doi: 10.1159/000362363. Epub 2014 May 24.
7
Block of the mevalonate pathway triggers oxidative and inflammatory molecular mechanisms modulated by exogenous isoprenoid compounds.
Int J Mol Sci. 2014 Apr 22;15(4):6843-56. doi: 10.3390/ijms15046843.
8
Cholesterol-responsive metabolic proteins are required for larval development in Caenorhabditis elegans.
Mol Cells. 2013 Nov;36(5):410-6. doi: 10.1007/s10059-013-0170-2. Epub 2013 Nov 8.
9
Sex-specific differences in the predictive value of cholesterol homeostasis markers and 10-year cardiovascular disease event rate in Framingham Offspring Study participants.
J Am Heart Assoc. 2013 Feb 19;2(1):e005066. doi: 10.1161/JAHA.112.005066.
10
A case report of prenatal exposure to rosuvastatin and telmisartan.
Paediatr Child Health. 2009 Sep;14(7):450-2.
本文引用的文献
1
Mevalonate kinase deficiency in a dizygotic twin with mild mevalonic aciduria.
J Inherit Metab Dis. 1997 Jul;20(3):391-4. doi: 10.1023/a:1005394315300.
2
New treatment strategy for Smith-Lemli-Opitz syndrome.
Lancet. 1997 Apr 26;349(9060):1222. doi: 10.1016/S0140-6736(05)62415-4.
3
Pathogenesis of malformations in a rodent model for Smith-Lemli-Opitz syndrome.
Am J Med Genet. 1997 Jan 31;68(3):328-37. doi: 10.1002/(sici)1096-8628(19970131)68:3<328::aid-ajmg15>3.0.co;2-v.
4
Cholesterol and bile acid replacement therapy in children and adults with Smith-Lemli-Opitz (SLO/RSH) syndrome.
Am J Med Genet. 1997 Jan 31;68(3):315-21. doi: 10.1002/(sici)1096-8628(19970131)68:3<315::aid-ajmg13>3.0.co;2-w.
5
Treatment of Smith-Lemli-Opitz syndrome: results of a multicenter trial.
Am J Med Genet. 1997 Jan 31;68(3):311-4.
6
Clinical effects of cholesterol supplementation in six patients with the Smith-Lemli-Opitz syndrome (SLOS).
Am J Med Genet. 1997 Jan 31;68(3):305-10. doi: 10.1002/(sici)1096-8628(19970131)68:3<305::aid-ajmg11>3.0.co;2-x.
7
Increased expression of low-density lipoprotein receptors in a Smith-Lemli-Opitz infant with elevated bilirubin levels.
Am J Med Genet. 1997 Jan 31;68(3):294-9. doi: 10.1002/(sici)1096-8628(19970131)68:3<294::aid-ajmg9>3.0.co;2-m.
8
Physical mapping of the chromosome 7 breakpoint region in an SLOS patient with t(7;20) (q32.1;q13.2).
Am J Med Genet. 1997 Jan 31;68(3):279-81.
9
Cardiovascular malformations in Smith-Lemli-Opitz syndrome.
Am J Med Genet. 1997 Jan 31;68(3):270-8.
10
Clinical and biochemical spectrum of patients with RSH/Smith-Lemli-Opitz syndrome and abnormal cholesterol metabolism.
Am J Med Genet. 1997 Jan 31;68(3):263-9.
Zotero 插件